Evidence-Based Neonatal Drug Therapy for Prevention of Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants

Publisher： Karger

E-ISSN： 1661-7819|93|4|284-287

ISSN： 1661-7800

Source： Neonatology, Vol.93, Iss.4, 2008-06, pp. : 284-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WEIGHT LOSS AND BRONCHOPULMONARY DYSPLASIA IN VERY LOW BIRTH WEIGHT INFANTS

By Maayan-Metzger Ayala   Mazkereth Ram   Kuint Jacob  

Fetal and Pediatric Pathology, Vol. 27, Iss. 4-5, 2008-12 ,pp. : 215-222

Informa Healthcare

Access to resources Recommend Favorite

Impact of Improved Survival of Very Low-Birth-Weight Infants on Incidence and Severity of Bronchopulmonary Dysplasia

By  

Neonatology, Vol. 86, Iss. 2, 2004-08 ,pp. : 124-130

Karger

Access to resources Recommend Favorite

An Elevation of Serum Ferritin Level Might Increase Clinical Risk for the Persistence of Patent Ductus Arteriosus, Sepsis and Bronchopulmonary Dysplasia in Erythropoietin-Treated Very-Low-Birth-Weight Infants

By  

Neonatology, Vol. 111, Iss. 1, 2016-08 ,pp. : 68-75

Karger

Access to resources Recommend Favorite

Glucocorticoid Receptor Gene Variants and Neonatal Outcome in Very-Low-Birth-Weight Preterm Infants

By  

Neonatology, Vol. 111, Iss. 1, 2016-08 ,pp. : 22-29

Karger

Access to resources Recommend Favorite

Early Inflammatory Markers for Prediction of Cholestasis in Very-Low-Birth-Weight Infants

By  

Neonatology, Vol. 102, Iss. 3, 2012-08 ,pp. : 229-234

Karger

Access to resources Recommend Favorite